Skip to main content
Fig. 3 | Journal of Cardiothoracic Surgery

Fig. 3

From: Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma

Fig. 3

Validation and analysis of prognostic risk signature. (A) Analysis of ROC curves in training cohort. (B) K-M curve analysis of high and low risk groups in training cohort. (C) Distribution of risk scores and survival status of high and low risk group in the training cohort. (D) Analysis of ROC curves in validation cohort. (E) K-M curve analysis in validation cohort. (F) Distribution of risk scores and survival status in the validation cohort. (G) Expression levels of prognostic signature genes between high and low risk groups in the training cohort. (H) Expression levels of prognostic signature genes in the validation cohort

Back to article page